NEW PUBLICATION

Christopher Rohde discuss the use of stimulants in patients with schizophrenia. In a register-based study the authors found that patients with schizophrenia treated with CNS stimulants has a reduced risk of psychiatric admission, fewer days per admission and lower use of antipsychotic medication.  Read more here (in Danish).

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s